BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 19, 2007
View Archived Issues
Esteve and AstraZeneca patents disclose therapeutic agents for metabolic disorders
Read More
Vertex updates recent developments, outlines 2007 goals
Read More
Ability of N-acetylcysteine to prevent acute renal failure in hypotensives unclear
Read More
Combined erythromycin/metoclopramide therapy shows promise in feed intolerance
Read More
Promising preclinical results for FK-734 in preventing transplant rejection
Read More
Inhibition of endocannabinoid degradation: a novel strategy for the treatment of Parkinson's disease
Read More
WHO awards prequalification status to Rotarix
Read More
Promising antitumor activity of combined therapy with docetaxel and the GHRH antagonist JMR-132
Read More
Viventia reviews late-stage antibody programs
Read More
Anavex Life Sciences reviews neurological pipeline
Read More
Lipomics to support Isis on metabolic drug testing
Read More
Promising results for Hylenex in INFUSE-Morphine study
Read More
MultiCell Technologies advances MCT-475 to preclinical development
Read More
Hemispherx updates avian flu program status
Read More
Kamada submits plans for phase II/III trial of aerosolized AAT
Read More
New phase IIb study evaluates NB-001 for herpes labialis
Read More
Rh-Apo2L begins phase II trials in China
Read More
Neocartilage begins clinical trial
Read More
Ariad advances phase III plans for AP-23573
Read More
Phase I results for SPI-1005 in noise-induced hearing loss reported at the ARO meeting
Read More
Ariad plans IND for AP-24534 for CML
Read More
Copernicus Therapeutics to receive further CFFT funding for CF gene therapy
Read More
Trend toward stabilization of CD4+ count in patients receiving Remune, IR-103
Read More
ELI-216 demonstrates euphoria blocking effect
Read More
Recent Gedeon Richter and Universitaet Wien patents disclose novel analgesic agents
Read More
Conditional approval for Prezista in E.U.
Read More
Priority review for ambrisentan NDA
Read More
Novel antiinfective agents disclosed in recent patent literature
Read More
